Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.930 | 2.930 | 0.000 |
Stocks | 97.070 | 97.070 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.324 | 21.892 |
Price to Book | 3.064 | 4.021 |
Price to Sales | 1.958 | 2.277 |
Price to Cash Flow | 12.429 | 17.046 |
Dividend Yield | 1.868 | 1.338 |
5 Years Earnings Growth | 9.868 | 11.286 |
Number of long holdings: 50
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
J&J | US4781601046 | 8.00 | 152.41 | -0.71% | |
AstraZeneca | GB0009895292 | 7.46 | 12,433.1 | +0.59% | |
Roche Holding Participation | CH0012032048 | 6.35 | 232.80 | +0.39% | |
Eli Lilly | US5324571083 | 6.15 | 804.09 | +0.15% | |
Lonza Group | CH0013841017 | 5.39 | 510.60 | 0.00% | |
UnitedHealth | US91324P1021 | 4.63 | 518.86 | -0.48% | |
Pfizer | US7170811035 | 4.53 | 28.84 | -2.55% | |
Vertex | US92532F1003 | 4.14 | 448.86 | +0.30% | |
Horizon Therapeutics PLC | IE00BQPVQZ61 | 3.96 | - | - | |
Thermo Fisher Scientific | US8835561023 | 3.89 | 590.40 | -0.07% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
NO0010827819 | 68.04B | 15.02 | 16.93 | 21.90 | ||
DNB Global indeks SEK | 61.58B | 9.82 | 13.27 | 15.16 | ||
DNB Teknologi SEK | 35.76B | -9.68 | 10.68 | 24.23 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review